Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

Published:2019-02 Issue:2 Volume:35 Page:329
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hellmann Matthew D.,Callahan Margaret K.,Awad Mark M.,Calvo Emiliano,Ascierto Paolo A.,Atmaca Akin,Rizvi Naiyer A.,Hirsch Fred R.,Selvaggi Giovanni,Szustakowski Joseph D.,Sasson Ariella,Golhar Ryan,Vitazka Patrik,Chang Han,Geese William J.,Antonia Scott J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy;International Immunopharmacology;2024-11

2. Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients;BMC Pulmonary Medicine;2024-08-29

3. Serum albumin and derived neutrophil-to-lymphocyte ratio are potential predictive biomarkers for immune checkpoint inhibitors in small cell lung cancer;Frontiers in Immunology;2024-06-07

4. A potassium‐chloride co‐transporter with altered genome architecture functions as a suppressor in glioma;Journal of Cellular and Molecular Medicine;2024-04-29

5. The immune response-related genomic alterations in patients with malignant melanoma;Medicine;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP